William Elliott – Making Sense of U.S. Hypertension Guidelines in 2019

Course Description

Archive : William Elliott – Making Sense of U.S. Hypertension Guidelines in 2019 Digital Download
Salepage : William Elliott – Making Sense of U.S. Hypertension Guidelines in 2019
Delivery : Online With Any Device

First presented at the OPSO Annual Primary Care CME Conference on September 27, 2019. Join us for this on-demand CME presentation where William Elliott, MD provides his insightful (and always entertaining) review of US Hypertnesion Guidelines.

Educational Objectives:

At the end of this presentation, the awake audience members should be able to:

1. Name at least one advantage and at least one disadvantage for the most current US hypertension guidelins(s) promulgated by:
2. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7),
3. The panel members appointed to JNC 8,
4. The American Society of Hypertension and the International Society of Hypertension,
5. The American Diabetes Association,
6. The National Kidney Foundation, and
7.   The American College of Cardiology and The American Heart Association.

Dr. Elliott discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of his presentation.

William J. Elliott, M.D., Ph.D. is Professor of Preventive Medicine,   Internal Medicine, and Pharmacology, Chief of the Division of Pharmacology, and Chair of The Department of Biomedical Sciences at the Pacific Northwest University of Health Sciences in Yakima, WA. After receiving the B.S. (summa cum laude) from the University of Notre Dame, he earned the M.D. and Ph.D. (in Bio-Organic Chemistry) from the University of Chicago. He trained in Internal Medicine and Pharmacology at Barnes Hospital and Washington University-St. Louis, and served as a member of the faculty of the University of Chicago from 1985-92. During the next 17 years at RUSH Medical College, he practiced, taught and did research on cardiovascular clinical pharmacology, focusing on epidemiologic studies of risk factors (including diagonal earlobe creases), laboratory investigations, federally-funded cooperative clinical trials, and many industry-supported endeavors, serving as principal investigator for about 200 clinical trials of new drugs.   Dr. Elliott holds Board Certification in both Internal Medicine and Clinical Pharmacology. One of the inaugural -Specialists in Clinical Hypertension and Fellows of the American Society of Hypertension, he contributed on five topics to   JNC VI, as well as to the -long version of JNC 7. Some of his recent publications include meta-analyses of clinical trial results, putative risk factors for cardiovascular disease, cost-containment, pharmacoeconomics, and the assessment and enhancement of medication adherence. Dr. Elliott belongs to many professional societies interested in clinical pharmacology and in hypertension, including fellowship in the American Heart Association’s High Blood Pressure Council. He has lectured on five continents, participated in the review process for many journals, societies, study sections, and funding agencies, and served as editor or co-editor for many books, monographs, and symposia. Among his honors are 29 awards for teaching excellence.